Deteksi Dini dan Penapisan Kadar Asam Urat Usia Produktif di SMA Kalam Kudus II, Jakarta
DOI:
https://doi.org/10.59841/jurai.v2i2.1233Keywords:
Health Education, Risk Factors, Hyperuricemia, Uric Acid Levels, DietAbstract
Uric acid is an end product of purine metabolism that can crystallize at high concentrations, causing gout and other related conditions. This study aims to describe the proportion and risk factors for hyperuricemia in the productive age population. This descriptive research was conducted in March 2024 at Kalam Kudus II High School, Duri Kosambi Village, using purposive sampling techniques. The sample consisted of 74 respondents aged 18-64 years. Data collection includes demographic characteristics and uric acid levels using the Point Of Care Testing (POCT) tool. The results showed that 67 respondents (90.5%) had normal uric acid levels, while 7 respondents (9.5%) had hyperuricemia. Identified risk factors include a high-purine diet, obesity, metabolic syndrome, certain medical conditions, and genetic factors. The results of this research are the importance of changing diet, weight loss, adequate hydration, and the use of medication in managing uric acid levels. Health education has proven important for improving patient compliance with diet and medication, as well as preventing complications. Therefore, it is necessary to develop comprehensive educational programs and further research to improve the treatment of hyperuricemia.
References
Ae, R., Kanbay, M., & Kuwabara, M. (2020). The causality between the serum uric acid level and stroke. Hypertension Research, 43(4), 354–356. https://doi.org/10.1038/s41440-019-0346-z
Aupia, A. (2021). The Effect of Health Education on The Knowledge and Adherence of Diet for Gout Arthritis Patients. Media Keperawatan Indonesia, 4(2), 120. https://doi.org/10.26714/mki.4.2.2021.120-126
Barbosa, M. C. C., Brandão, A. P. A. A., Pozzan, R., Magalhães, M. E. C., Campana, É. M. G., Fonseca, F. L., Pizzi, O. L., Freitas, E. V. de, & Brandão, A. P. A. A. (2011). Associação entre ácido úrico e variáveis de risco cardiovascular em uma população não hospitalar. Arquivos Brasileiros de Cardiologia, 96(3), 212–218. https://doi.org/10.1590/S0066-782X2011005000011
DEL PINTO, R., VIAZZI, F., PONTREMOLI, R., FERRI, C., CARUBBI, F., & RUSSO, E. (2021). The URRAH study. Panminerva Medica, 63(4). https://doi.org/10.23736/S0031-0808.21.04357-3
Denys, K., Cankurtaran, M., Janssens, W., & Petrovic, M. (2009). METABOLIC SYNDROME IN THE ELDERLY: AN OVERVIEW OF THE EVIDENCE. Acta Clinica Belgica, 64(1), 23–34. https://doi.org/10.1179/acb.2009.006
Destra, E., & Firmansyah, Y. (2022). Intervention Program in Effort to Reduce New Cases. Jurnal Pengabdian Mandiri, 1(5), 677–682. https://www.bajangjournal.com/index.php/JPM/article/view/2155/1534
Dorobanțu, M., Halațiu, V.-B., Gheorghe-Fronea, O., Bala, C.-G., Moldovan, H., Irinel-Parepa, R., Rodean, I.-P., Benedek, I., & Benedek, T. (2023). The Association between Apolipoprotein B, Cardiovascular Risk Factors and Subclinical Atherosclerosis-Findings from the SEPHAR National Registry on Hypertension in Romania. International Journal of Molecular Sciences, 24(3). https://doi.org/10.3390/ijms24032813
Gagliardi, A. C. M., Miname, M. H., & Santos, R. D. (2009). Uric acid: A marker of increased cardiovascular risk. Atherosclerosis, 202(1), 11–17. https://doi.org/10.1016/j.atherosclerosis.2008.05.022
Hayati, Y. S., Putri, V. A., & Lukitasari, M. (2020). THE EFFECTIVENESS OF LUNG TUBERCULOSIS EDUCATIONAL VIDEO TO INCREASE KNOWLEDGE AND ATTITUDES OF MASKS USE IN FAMILIES LIVING WITH TUBERCULOSIS PATIENTS. Journal of Nursing Science Update (JNSU), 8(2), 129–134. https://doi.org/10.21776/ub.jik.2020.008.02.10
Kang, D.-H. (2010). Potential Role of Uric Acid as a Risk Factor for Cardiovascular Disease. The Korean Journal of Internal Medicine, 25(1), 18. https://doi.org/10.3904/kjim.2010.25.1.18
King, C., Lanaspa, M. A., Jensen, T., Tolan, D. R., Sánchez-Lozada, L. G., & Johnson, R. J. (2018). Uric Acid as a Cause of the Metabolic Syndrome (pp. 88–102). https://doi.org/10.1159/000484283
Kurniari, P. K., Kambayana, G., & Putra, T. R. (2011). HUBUNGAN HIPERURISEMIA DAN FRACTION URIC ACID CLEARANCE DI DESA TENGANAN PEGRINGSINGAN KARANGASEM BALI. Journal of Internal Medicine, 12. https://api.semanticscholar.org/CorpusID:70898997
Petrovic, D., Tirmenstajn-Jankovic, B., Zivanovic, M., Petrovic-Nikolic, A., Nikolic, A., Jovanovic, M., & Poskurica, M. (2016). Hyperuricemia: A risk factor for the development and progression of chronic kidney disease. Timocki Medicinski Glasnik, 41(4), 319–326. https://doi.org/10.5937/tmg1604319P
Raina, S. S., Raina, R., & Raina, S. S. (2015). Hyperuricemia: A risk factor beyond gout. Journal of Obesity and Metabolic Research, 2(4), 228. https://doi.org/10.4103/2347-9906.170903
Ruslim, D., Destra, E., Kurniawan, J., & Firmansyah, Y. (2023). Pengaruh Kadar High Density Lipoprotein (HDL) dan Usia terhadap Kejadian Peripheral Arterial Disease (PAD). Termometer: Jurnal Ilmiah Ilmu Kesehatan Dan Kedokteran, 1(3), 180–190. https://doi.org/10.55606/TERMOMETER.V1I3.2059
Setyanda, Y. O. G., Sulastri, D., & Lestari, Y. (2015). Hubungan Merokok dengan Kejadian Hipertensi pada Laki-Laki Usia 35-65 Tahun di Kota Padang. Jurnal Kesehatan Andalas, 4(2). https://doi.org/10.25077/jka.v4i2.268
Țăpoi, L., Șalaru, D. L., Sascău, R., & Stătescu, C. (2021). Uric Acid—An Emergent Risk Marker for Thrombosis? Journal of Clinical Medicine, 10(10), 2062. https://doi.org/10.3390/jcm10102062
Wełniak, A., Białczyk, A., Wójcik, A., Zduńczyk, N., Górka, A., Jaśniak, A., Lazarek, M., Prudzic, P., Załęcki, P., & Kędziora-Kornatowska, K. (2022). HYPERURICEMIA AS AN INTERDISCIPLINARY PROBLEM. Issues of Rehabilitation, Orthopaedics, Neurophysiology and Sport Promotion – IRONS, 41, 15–25. https://doi.org/10.19271/IRONS-000176-2022-41
Yan, S., Zhang, P., Xu, W., Liu, Y., Wang, B., Jiang, T., Hua, C., Wang, X., Xu, D., & Sun, B. (2015). Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis. Mediators of Inflammation, 2015, 1–7. https://doi.org/10.1155/2015/764250
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2021). Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. International Journal of Molecular Sciences, 22(17), 9221. https://doi.org/10.3390/ijms22179221
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 jurnal ABDIMAS Indonesia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
